LA BioMed Medical/Research Briefs, July/August 2004

  • LA BioMed Supports Stem Cell Initiative
  • Ethnic Breast Cancer?
  • A Periodic Table For Biology

    La BioMed Supports Stem Cell Initiative

    In coalition with major health and business groups throughout California, LA BioMed has indicated its support for the California Stem Cell Bond Issue Initiative that recently qualified for November's ballot. The initiative will allocate money from a $3 billion bond to fund promising, California-based stem cell research.

    The initiative will distribute an average of $295 million per year over a 10-year period to fund stem cell research at California's universities and other advanced medical research facilities. It will fund all aspects of stem cell therapy development from basic research through clinical trials to the actual delivery of therapies to patients.

    Kenneth P. Trevett, President and CEO of LA BioMed, recently issued the following statement about the initiative:

    The stem cell initiative is a necessary step in the pursuit of scientific research because federal funding for stem cell research has been limited. Unquestionably, stem cell therapy is potentially the most important medical advance since the discovery of antibiotics. This critically important statewide initiative closes the federal funding gap and sets a new state model for advancing scientific research. From an economic standpoint, California will benefit from patents and royalties that result from the research. Construction of research facilities and new research jobs will generate millions of dollars in new tax revenues for California. More importantly, if stem cell research results in a single cure that reduces healthcare costs by just one percent, it would pay for itself several times over during the following decade and save lives along the way.

    Mr. Trevett is available to speak the merits of the stem cell initiative. To contact him, telephone or e-mail the Communicatio

  • Contact: David Feuerherd
    Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)

    Page: 1 2 3

    Related biology news :

    1. BioMed Central to consult funders and librarians over Open Access payment model
    2. BioMed Central explodes Open Access myths
    3. The Scientist and BioMed Central come together to publish high-impact magazine
    4. BioMed Central is pleased to announce the publication of Sydney Brenners autobiography
    5. BioMed Central to deposit e-journals with the British Library
    6. BioMed Central to consider charging authors for paper submissions
    7. Get Research on the move with BioMed Central
    8. BioMed Central to launch at microbiology meeting
    9. BioMed Central to free scientists and clinical researchers from copyright restrictions

    Post Your Comments:

    (Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
    (Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
    (Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
    Breaking Biology News(10 mins):
    (Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded ... of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for ... fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates ...
    (Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
    (Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
    (Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
    Breaking Biology Technology:
    Cached News: